VocaMedi
HomeMedical DictionaryLichen planopilaris
📢Advertisement[top]
ICD-10: L66.1Inflammatory scalp disorderAUTOIMMUNEDERMATOLOGICAL

Lichen planopilaris

LIE-ken plan-oh-pie-LAR-is

Also known as: LPP, Follicular lichen planus

Medical Disclaimer: This information is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

At a Glance

Type
Inflammatory scalp disorder
Age of Onset
Middle adulthood
Inheritance
Not typically inherited
Prevalence
Approximately 1 in 100,000

What is Lichen planopilaris?

Lichen planopilaris is a rare inflammatory condition that primarily affects the scalp, leading to hair loss. It is an autoimmune disorder where the body's immune system mistakenly attacks hair follicles. The condition usually begins with redness and irritation on the scalp, followed by patchy hair loss. Over time, the affected areas can become smooth and shiny due to scarring, making hair regrowth unlikely. Early symptoms include itching and burning sensations, while later stages may involve significant hair thinning and bald patches. Early diagnosis is crucial to manage symptoms and prevent irreversible hair loss. The condition can be distressing for affected individuals and their families, impacting self-esteem and quality of life. While the prognosis varies, some people may experience periods of remission. Daily life for those affected often involves managing symptoms with medications and regular dermatological care. It is not life-threatening, but it can be emotionally challenging. Support groups and counseling may be beneficial for coping with the psychological impact. Treatment focuses on reducing inflammation and slowing the progression of hair loss.

Medical Definition

Lichen planopilaris is a chronic lymphocytic folliculitis characterized by perifollicular inflammation and destruction of hair follicles. Histologically, it presents with lichenoid tissue reaction and a band-like infiltrate of lymphocytes at the dermal-epidermal junction. It is classified under primary cicatricial alopecias, with a higher prevalence in middle-aged women. Epidemiologically, it is considered a rare condition with an incidence of approximately 1 in 100,000 individuals. The disease course is variable, with some patients experiencing rapid progression and others having a more indolent course. Management involves immunosuppressive therapies to control inflammation and prevent further hair loss.

Lichen planopilaris Symptoms

Symptoms vary in severity between individuals. Early diagnosis and management can significantly improve outcomes.

Very Common

Scalp pruritus

Scalp pruritus manifests as an intense itching sensation on the scalp. It is caused by inflammation of the hair follicles due to an autoimmune response. Over time, the itching can lead to scratching, which may exacerbate inflammation and lead to further hair loss. This symptom can significantly affect daily life by causing discomfort and sleep disturbances, and topical corticosteroids or antihistamines can be used to manage it.

Hair loss

Hair loss in lichen planopilaris is typically patchy and progressive, often starting at the frontal hairline. The biological mechanism involves the destruction of hair follicles by lymphocytic infiltration. As the condition progresses, permanent scarring alopecia can occur, leading to irreversible hair loss. This affects the patient's self-esteem and social interactions, and early intervention with medications like hydroxychloroquine can help slow progression.

Scalp tenderness

Scalp tenderness is experienced as pain or discomfort when touching or combing the hair. It results from inflammation and damage to the scalp's nerve endings. The tenderness can become more pronounced as the disease progresses, especially in areas with active inflammation. This symptom can limit hair care practices and may require analgesics or anti-inflammatory treatments for relief.

Common

Scalp erythema

Scalp erythema presents as redness of the scalp skin, indicating underlying inflammation. It is caused by increased blood flow to the affected areas as part of the body's immune response. The erythema may fluctuate in intensity over time, often correlating with disease activity. This can lead to cosmetic concerns for patients, and treatments like topical steroids can help reduce the redness.

Follicular hyperkeratosis

Follicular hyperkeratosis appears as small, rough bumps around hair follicles, resembling goosebumps. It is due to an overproduction of keratin, leading to blockage of the hair follicle opening. This condition can persist and worsen with ongoing inflammation, contributing to hair loss. Regular exfoliation and keratolytic agents can help manage this symptom.

Scalp scaling

Scalp scaling is characterized by the presence of dry, flaky skin on the scalp. It occurs due to excessive shedding of the outer skin layer, often exacerbated by inflammation. Scaling can be persistent and may lead to dandruff-like flakes on clothing. Moisturizing shampoos and topical treatments can help alleviate this symptom.

Less Common

Scalp burning sensation

A burning sensation on the scalp is described as a feeling of heat or stinging. This is caused by nerve irritation due to inflammation and follicular damage. The sensation may come and go, often worsening during flare-ups. It can be distressing for patients, and cooling agents or topical anesthetics may provide temporary relief.

Emotional distress

Emotional distress arises from the impact of visible hair loss and chronic symptoms on mental health. The stress and anxiety are often a response to changes in appearance and social stigma. Over time, this can lead to depression or social withdrawal if not addressed. Psychological support and counseling, along with support groups, can be beneficial for affected individuals.

What Causes Lichen planopilaris?

Lichen planopilaris is a condition with an unclear genetic basis, as no specific causative gene has been definitively identified. However, it is hypothesized that genetic predispositions may play a role, potentially involving genes related to immune regulation. The normal function of these genes typically involves encoding proteins that help regulate immune responses and maintain skin and hair follicle integrity. Mutations or dysregulation in these genes could lead to an aberrant immune response, causing the immune system to mistakenly attack hair follicles. This autoimmune reaction results in inflammation and destruction of the hair follicle structure, leading to scarring alopecia. The immediate molecular consequence inside the cell includes the activation of inflammatory pathways and cytokine release. This inflammation disrupts normal cellular functions and can lead to apoptosis of follicular keratinocytes. The dysfunction of hair follicle organelles and pathways results in the inability to sustain hair growth. Neighboring cells and tissues are affected as the inflammatory process extends, leading to further tissue damage and fibrosis. Neuroinflammation and immune responses play a crucial role in perpetuating the disease process. As inflammation persists, it contributes to the degeneration of hair follicle structures and surrounding tissues. Symptoms appear in a specific pattern due to the localized nature of the autoimmune attack on hair follicles. Disease severity varies between patients due to differences in genetic predisposition, immune system activity, and environmental factors.

📢Advertisement[mid-content]

How is Lichen planopilaris Diagnosed?

Typical age of diagnosis: Lichen planopilaris is typically diagnosed in adults between the ages of 30 and 60, with a higher prevalence in women. Diagnosis often occurs after patients present with symptoms such as scalp itching, burning, or hair loss. The condition is frequently identified during dermatological evaluations when patients seek help for unexplained hair thinning. Early diagnosis is crucial to prevent irreversible hair loss and manage symptoms effectively.

1
Clinical Evaluation

Clinicians look for signs of perifollicular erythema, follicular hyperkeratosis, and scarring alopecia. A thorough patient history is taken, focusing on the duration of symptoms, any associated autoimmune conditions, and family history of similar symptoms. Physical examination findings include patchy hair loss with perifollicular scaling and erythema. This step helps differentiate lichen planopilaris from other causes of scarring alopecia and guides further diagnostic testing.

2
Imaging Studies

Trichoscopy is the imaging modality commonly used, revealing specific abnormalities such as perifollicular scaling and blue-gray dots. These findings help confirm the diagnosis by visualizing the characteristic features of lichen planopilaris. Imaging studies also assist in excluding differentials like alopecia areata and discoid lupus erythematosus. The presence of these trichoscopic patterns supports the clinical suspicion and directs the need for biopsy.

3
Laboratory Tests

Laboratory tests may include a complete blood count, thyroid function tests, and autoimmune panels to rule out associated conditions. Biomarkers such as antinuclear antibodies may be sought to identify concurrent autoimmune disorders. Abnormal results could show elevated inflammatory markers or thyroid dysfunction, which may correlate with disease activity. These results guide the clinician in tailoring a comprehensive management plan and monitoring for systemic involvement.

4
Genetic Testing

Currently, there are no specific genes sequenced for lichen planopilaris as its genetic basis is not well-defined. However, research into potential genetic predispositions is ongoing, focusing on mutations that may contribute to autoimmune susceptibility. While genetic testing does not confirm the diagnosis, it may provide insights into familial patterns and risk factors. This information can be valuable for family counseling and understanding the hereditary aspects of the condition.

Lichen planopilaris Treatment Options

⚠️ All treatment decisions should be made in consultation with a specialist experienced in this condition.
PharmacologicalCorticosteroids

Corticosteroids are a class of anti-inflammatory drugs that suppress the immune response. They are used topically or systemically to reduce inflammation and slow disease progression. Specific drugs include clobetasol propionate and oral prednisone. Clinical evidence supports their efficacy in decreasing scalp inflammation and halting hair loss. Limitations include potential side effects such as skin atrophy and systemic complications with long-term use.

Physical TherapyScalp Massage Therapy

Scalp massage therapy involves gentle manipulation of the scalp to improve blood circulation and reduce tension. The therapeutic goals are to enhance scalp health and potentially stimulate hair growth. Sessions are typically conducted weekly for 20-30 minutes over several months. Measurable outcomes include improved scalp condition and patient-reported reduction in symptoms like itching. Long-term benefits may include better scalp health and reduced stress levels.

SurgicalHair Transplantation

Hair transplantation is indicated for patients with stable disease and significant hair loss. The procedure involves transplanting hair follicles from unaffected areas to bald patches. Expected benefits include improved cosmetic appearance and patient satisfaction. Surgical risks include infection, scarring, and graft failure. Post-operative care requires careful monitoring and adherence to scalp care instructions to ensure optimal results.

Supportive CareMultidisciplinary Care Model

The care team typically includes dermatologists, psychologists, and trichologists. Specific interventions focus on managing symptoms, providing psychological support, and educating patients about the condition. Psychosocial support strategies involve counseling and support groups to address emotional impacts. Family education includes information on disease management and genetic counseling. A long-term monitoring plan ensures regular follow-ups to assess disease progression and treatment efficacy.

When to See a Doctor for Lichen planopilaris

🔴 Seek Emergency Care Immediately
  • Sudden and severe hair loss — this could indicate rapid progression of the condition requiring immediate medical intervention.
  • Intense scalp pain or burning sensation — may suggest an acute inflammatory response needing urgent treatment.
  • Signs of infection such as fever or pus on the scalp — could indicate a secondary infection requiring prompt antibiotic therapy.
🟡 Contact Your Doctor Soon
  • Persistent itching or discomfort on the scalp — may indicate ongoing inflammation and should be evaluated by a dermatologist.
  • Noticeable thinning of hair over weeks to months — suggests disease progression and warrants a medical review.
  • Development of new bald patches — could indicate worsening of the condition and should be discussed with a healthcare provider.
🟢 Monitor at Home
  • Mild scalp itching — monitor for any increase in severity or spread and maintain regular scalp care.
  • Occasional hair shedding — keep track of the amount and frequency, and consult a doctor if it worsens.

Lichen planopilaris — Frequently Asked Questions

Is this condition hereditary?

Lichen planopilaris is not typically considered a hereditary condition, as it does not follow a clear inheritance pattern. The probability of passing it to children is low, and it is not associated with de novo mutations. There are no known carrier states for this condition. Genetic counseling is generally not necessary, but may be considered if there is a family history of similar autoimmune conditions. It is important to discuss any concerns with a healthcare provider.

What is the life expectancy for someone with this condition?

Lichen planopilaris does not typically affect life expectancy, as it primarily impacts the scalp and hair. Prognosis can vary based on age of onset, with earlier intervention often leading to better outcomes. The condition itself does not cause mortality, but it can significantly impact quality of life. Effective treatment can help manage symptoms and improve daily functioning. Patients should have realistic expectations about the chronic nature of the condition and the potential for flare-ups.

How is this condition diagnosed and how long does diagnosis take?

Diagnosis of lichen planopilaris involves a clinical examination, trichoscopy, and often a scalp biopsy. The time from first symptoms to diagnosis can vary, typically taking several months due to the subtle onset of symptoms. Dermatologists are the primary specialists involved, though rheumatologists may be consulted for autoimmune evaluation. Delayed diagnosis is common due to the overlap of symptoms with other scalp conditions. A biopsy confirming lichenoid infiltrate is often the definitive step in diagnosis.

Are there any new treatments or clinical trials available?

Current research is exploring the role of novel immunomodulatory therapies in managing lichen planopilaris. Gene therapy is not yet applicable, but biologics and JAK inhibitors show promise. ClinicalTrials.gov is a resource for finding ongoing trials, and patients should discuss eligibility with their healthcare provider. It is important to ask about the potential benefits and risks of participating in a trial. New treatments may become available in the next few years, but timelines are uncertain.

How does this condition affect daily life and activities?

Lichen planopilaris can impact daily life by causing discomfort and self-consciousness due to hair loss. It does not typically affect mobility or self-care, but can have educational and social implications, particularly for children and adolescents. Emotional challenges such as anxiety and depression are common due to the visible nature of the condition. Family members may experience a burden in providing support and care. Support groups and counseling can be beneficial in managing these challenges.

Learn More

🔬 Focal palmoplantar keratoderma with joint keratoses🔬 Infection-related hemolytic uremic syndrome🔬 Guillain-Barré syndrome🔬 Graft versus host disease

Support & Resources

National Alopecia Areata Foundation
The National Alopecia Areata Foundation provides support and resources for individuals with various forms of alopecia, including lichen planopilaris. They offer educational materials, support groups, and advocacy initiatives. Individuals can connect with them through their website or local chapters.
American Hair Loss Association
The American Hair Loss Association is dedicated to educating the public and healthcare professionals about hair loss disorders. They provide information on treatment options, research updates, and support networks. Membership and resources are accessible through their website.
🎓
Reviewed by a Health Management Academic
Öğr. Gör. Ahmet Bülbül ↗
Health Management · Health Psychology · Health Economics · Organizational Psychology
Academic since 2020 · Last reviewed: May 2026

References

Content generated with support from peer-reviewed literature via PubMed.

  1. 1.
    Lichen planopilaris and frontal fibrosing alopecia: review and update of diagnostic and therapeutic features.

    Fechine COC, Valente NYS, Romiti R · An Bras Dermatol · 2022 · PMID: 35379508

  2. 2.
    Lichen Planopilaris.

    Xie F, Lehman JS · Mayo Clin Proc · 2022 · PMID: 35120689

  3. 3.
    Lichen Planopilaris.

    Lepe K, Nassereddin A, Syed HA et al. · Unknown Journal · 2026 · PMID: 29262050

  4. 4.
    Lichen Planopilaris Trichoscopy in Caucasian Scalp: A Review.

    Orlando G, Rapparini L, Bruni F · Skin Appendage Disord · 2024 · PMID: 39659655

  5. 5.
    A Practical Approach to the Diagnosis and Management of Classic Lichen Planopilaris.

    Svigos K, Yin L, Fried L et al. · Am J Clin Dermatol · 2021 · PMID: 34347282

  6. 6.
    Lichen Planopilaris in Children: A Systematic Review.

    Papierzewska M, Waśkiel-Burnat A, Rudnicka L · Pediatr Dermatol · 2025 · PMID: 39629624

  7. 7.
    Lichen planopilaris: A review of evaluation methods.

    Naeini FF, Saber M, Faghihi G · Indian J Dermatol Venereol Leprol · 2021 · PMID: 33871194

  8. 8.
    Lichen planopilaris.

    Kang H, Alzolibani AA, Otberg N et al. · Dermatol Ther · 2008 · PMID: 18715294

This content is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.Last reviewed: 2026-05-11